Epidemiology of Community-Acquired Clostridium difficile-Associated Diarrhea
The epidemiology of clinically recognized community-acquired Clostridium difficile-associated diarrhea was assessed in a retrospective cohort study of members of a health maintenance organization (HMO). Potential cases were identified through positive toxin assay results and confirmed by review of a...
Saved in:
Published in | The Journal of infectious diseases Vol. 169; no. 1; pp. 127 - 133 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Chicago, IL
The University of Chicago Press
01.01.1994
University of Chicago Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The epidemiology of clinically recognized community-acquired Clostridium difficile-associated diarrhea was assessed in a retrospective cohort study of members of a health maintenance organization (HMO). Potential cases were identified through positive toxin assay results and confirmed by review of automated full-text medical records. Of 51 cases identified (7.7 per 100,000 person-years), 42 (82%) were diagnosed and treated exclusively in the ambulatory care setting; 33 cases occurred within 42 days after 494,491 exposures to antibiotics dispensed by an HMO pharmacy. Antibiotic-specific attack rates varied from 0 to 2040 cases per 100,000 exposures. Increased age was associated with C. difjiciie-associated diarrhea (P < .001). Age-adjusted antibiotic-specific attack rates were at least 10-fold higher (P < .05) for nitrofurantoin, cefuroxime, cephalexin plus dicloxacillin, ampicillinjclavulanate plus cefaclor, and ampicillin/clavulanate plus cefuroxime than for ampicillin or amoxicillin; several other antibiotics were associated with similar but not significantly increased risks. |
---|---|
Bibliography: | Reprints or correspondence: Dr. Richard Platt, Channing Laboratory, 180 Longwood Ave., Boston, MA 02115. istex:30620E31C80D5189A8E66BCE3E6C700F5BF43498 Present affiliation: Department of Medicine, Boston University School of Medicine, Boston. ark:/67375/HXZ-83RVJSFH-V ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0022-1899 1537-6613 |
DOI: | 10.1093/infdis/169.1.127 |